uniQure
QURE
#5501
Rank
A$1.92 B
Marketcap
A$30.90
Share price
-1.20%
Change (1 day)
172.54%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -A$0.36 Billion

According to uniQure's latest financial reports the company's current earnings are A$15.75 Million. In 2024 the company made an earning of -A$0.36 Billion, an increase over its 2023 earnings that were of -A$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.36 Billion-1.67%
2024 -A$0.36 Billion-22.65%
2023 -A$0.47 Billion139.01%
2022 -A$0.2 Billion-138.54%
2021 A$0.50 B-335.29%
2020 -A$0.22 Billion13.88%
2019 -A$0.19 Billion49.51%
2018 -A$0.13 Billion4.55%
2017 -A$0.12 Billion12.65%
2016 -A$0.11 Billion-9.59%
2015 -A$0.12 Billion66.95%
2014 -A$70.35 Million30.8%
2013 -A$53.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.40 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.17 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-A$0.31 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-A$0.83 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.69 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
A$1.02 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA